keyboard_backspaceTransitional cell carcinoma, NOS

Domain IDObservation
Concept Class IDICDO Histology
Vocabulary ID
ICDO3
help_outline
International Classification of Diseases for Oncology, Third Edition (WHO)
ICDO3 SEER Site/Histology Released 06/2020
https://seer.cancer.gov/icd-o-3/
Concept ID44498724
Concept code8120/3
ValidityValid
ConceptNon-standard

Language	Synonym Concept
English	Urothelial carcinoma, NOS

Valid start18-Sep-2015
Valid end31-Dec-2099

Term connections (123)

Relationship	Relates to	Concept id	Vocabulary
Histology of ICDO	Neoplasm defined only by histology: Transitional cell carcinoma, NOS	42513082	ICDO3
	Transitional cell carcinoma, NOS, of accessory sinus, NOS	36525972	ICDO3
	Transitional cell carcinoma, NOS, of anal canal	36563072	ICDO3
	Transitional cell carcinoma, NOS, of anterior surface of epiglottis	36533052	ICDO3
	Transitional cell carcinoma, NOS, of anterior wall of bladder	44501931	ICDO3
	Transitional cell carcinoma, NOS, of anterior wall of nasopharynx	36567309	ICDO3
	Transitional cell carcinoma, NOS, of anus, NOS	36546863	ICDO3
	Transitional cell carcinoma, NOS, of bladder neck	44501881	ICDO3
	Transitional cell carcinoma, NOS, of bladder, NOS	44505768	ICDO3
	Transitional cell carcinoma, NOS, of body of penis	36546764	ICDO3
	Transitional cell carcinoma, NOS, of branchial cleft	36546679	ICDO3
	Transitional cell carcinoma, NOS, of broad ligament	36545553	ICDO3
	Transitional cell carcinoma, NOS, of cervix uteri	36561534	ICDO3
	Transitional cell carcinoma, NOS, of choroid	36543772	ICDO3
	Transitional cell carcinoma, NOS, of ciliary body	36519010	ICDO3
	Transitional cell carcinoma, NOS, of clitorus	36547714	ICDO3
	Transitional cell carcinoma, NOS, of cloacogenic zone	36563791	ICDO3
	Transitional cell carcinoma, NOS, of conjunctiva	36532531	ICDO3
	Transitional cell carcinoma, NOS, of cornea, NOS	36567882	ICDO3
	Transitional cell carcinoma, NOS, of corpus uteri	36545227	ICDO3
	Transitional cell carcinoma, NOS, of dome of bladder	44503205	ICDO3
	Transitional cell carcinoma, NOS, of endocervix	36538630	ICDO3
	Transitional cell carcinoma, NOS, of endometrium	44500868	ICDO3
	Transitional cell carcinoma, NOS, of epididymis	36558690	ICDO3
	Transitional cell carcinoma, NOS, of ethmoid sinus	36537726	ICDO3
	Transitional cell carcinoma, NOS, of exocervix	36529969	ICDO3
	Transitional cell carcinoma, NOS, of eye, NOS	36528239	ICDO3
	Transitional cell carcinoma, NOS, of fallopian tube	44502695	ICDO3
	Transitional cell carcinoma, NOS, of female genital tract, NOS	36528644	ICDO3
	Transitional cell carcinoma, NOS, of frontal sinus	36568020	ICDO3
	Transitional cell carcinoma, NOS, of fundus uteri	36565986	ICDO3
	Transitional cell carcinoma, NOS, of gastrointestinal tract, NOS	36566504	ICDO3
	Transitional cell carcinoma, NOS, of glans penis	44499430	ICDO3
	Transitional cell carcinoma, NOS, of glottis	36536198	ICDO3
	Transitional cell carcinoma, NOS, of hypopharyngeal aspect of aryepiglottic fold	36522629	ICDO3
	Transitional cell carcinoma, NOS, of hypopharynx, NOS	36538480	ICDO3
	Transitional cell carcinoma, NOS, of ill-defined sites within respiratory system	36556665	ICDO3
	Transitional cell carcinoma, NOS, of intestinal tract, NOS	36562761	ICDO3
	Transitional cell carcinoma, NOS, of isthmus uteri	36551431	ICDO3
	Transitional cell carcinoma, NOS, of kidney, NOS	44505666	ICDO3
	Transitional cell carcinoma, NOS, of labium majus	36526360	ICDO3
	Transitional cell carcinoma, NOS, of labium minus	36554432	ICDO3
	Transitional cell carcinoma, NOS, of lacrimal gland	36560550	ICDO3
	Transitional cell carcinoma, NOS, of laryngeal cartilage	36539304	ICDO3
	Transitional cell carcinoma, NOS, of larynx, NOS	36539780	ICDO3
	Transitional cell carcinoma, NOS, of lateral wall of bladder	44500436	ICDO3
	Transitional cell carcinoma, NOS, of lateral wall of nasopharynx	36520402	ICDO3
	Transitional cell carcinoma, NOS, of lateral wall of oropharynx	36528933	ICDO3
	Transitional cell carcinoma, NOS, of liver	1553602	ICDO3
	Transitional cell carcinoma, NOS, of lower lobe, lung	36525385	ICDO3
	Transitional cell carcinoma, NOS, of lung, NOS	44500587	ICDO3
	Transitional cell carcinoma, NOS, of main bronchus	36550929	ICDO3
	Transitional cell carcinoma, NOS, of male genital organs, NOS	44499496	ICDO3
	Transitional cell carcinoma, NOS, of maxillary sinus	44499731	ICDO3
	Transitional cell carcinoma, NOS, of middle ear	36553098	ICDO3
	Transitional cell carcinoma, NOS, of middle lobe, lung	36554307	ICDO3
	Transitional cell carcinoma, NOS, of myometrium	36530284	ICDO3
	Transitional cell carcinoma, NOS, of nasal cavity	36522332	ICDO3
	Transitional cell carcinoma, NOS, of nasopharynx, NOS	36525417	ICDO3
	Transitional cell carcinoma, NOS, of orbit, NOS	36558303	ICDO3
	Transitional cell carcinoma, NOS, of oropharynx, NOS	36559294	ICDO3
	Transitional cell carcinoma, NOS, of other specified parts of female genital organs	36522998	ICDO3
	Transitional cell carcinoma, NOS, of other specified parts of male genital organs	36566947	ICDO3
	Transitional cell carcinoma, NOS, of ovary	44500991	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of accessory sinuses	36518046	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of bladder	36532537	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of cervix uteri	36531274	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of corpus uteri	36542272	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of digestive system	36554064	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of eye and adnexa	36538738	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of female genital organs	36528788	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of hypopharynx	36564989	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of larynx	36563801	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of lung	36557711	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of male genital organs	36527890	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of nasopharynx	36519108	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of penis	36537386	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of rectum, anus and anal canal	36547319	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of respiratory system and intrathoracic organs	36527621	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of tonsil	36539733	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of urinary organs	36519800	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesion of vulva	36524359	ICDO3
	Transitional cell carcinoma, NOS, of overlapping lesions of oropharynx	36560488	ICDO3
	Transitional cell carcinoma, NOS, of parametrium	36551827	ICDO3
	Transitional cell carcinoma, NOS, of paraurethral gland	36568178	ICDO3
	Transitional cell carcinoma, NOS, of penis, NOS	36554252	ICDO3
	Transitional cell carcinoma, NOS, of postcricoid region	36518118	ICDO3
	Transitional cell carcinoma, NOS, of posterior wall of bladder	44500858	ICDO3
	Transitional cell carcinoma, NOS, of posterior wall of hypopharynx	36533665	ICDO3
	Transitional cell carcinoma, NOS, of posterior wall of nasopharynx	36529484	ICDO3
	Transitional cell carcinoma, NOS, of posterior wall of oropharynx	36545871	ICDO3
	Transitional cell carcinoma, NOS, of prepuce	36547019	ICDO3
	Transitional cell carcinoma, NOS, of prostate gland	44501195	ICDO3
	Transitional cell carcinoma, NOS, of pyriform sinus	36545469	ICDO3
	Transitional cell carcinoma, NOS, of rectum, NOS	44501880	ICDO3
	Transitional cell carcinoma, NOS, of renal pelvis	44500857	ICDO3
	Transitional cell carcinoma, NOS, of retina	36532867	ICDO3
	Transitional cell carcinoma, NOS, of round ligament	36517588	ICDO3
	Transitional cell carcinoma, NOS, of scrotum, NOS	36542162	ICDO3
	Transitional cell carcinoma, NOS, of spermatic cord	36553326	ICDO3
	Transitional cell carcinoma, NOS, of sphenoid sinus	36567707	ICDO3
	Transitional cell carcinoma, NOS, of subglottis	36539061	ICDO3
	Transitional cell carcinoma, NOS, of superior wall of nasopharynx	36533576	ICDO3
	Transitional cell carcinoma, NOS, of supraglottis	36543012	ICDO3
	Transitional cell carcinoma, NOS, of tonsil, NOS	36561694	ICDO3
	Transitional cell carcinoma, NOS, of tonsillar fossa	36519420	ICDO3
	Transitional cell carcinoma, NOS, of tonsillar pillar	36567318	ICDO3
	Transitional cell carcinoma, NOS, of trigone of bladder	44500588	ICDO3
	Transitional cell carcinoma, NOS, of unknown primary site	36402529	ICDO3
	Transitional cell carcinoma, NOS, of upper lobe, lung	44503204	ICDO3
	Transitional cell carcinoma, NOS, of upper respiratory tract, NOS	36550580	ICDO3
	Transitional cell carcinoma, NOS, of urachus	36532240	ICDO3
	Transitional cell carcinoma, NOS, of ureter	44505703	ICDO3
	Transitional cell carcinoma, NOS, of ureteric orifice	44503077	ICDO3
	Transitional cell carcinoma, NOS, of urethra	44505776	ICDO3
	Transitional cell carcinoma, NOS, of urinary system, NOS	44501785	ICDO3
	Transitional cell carcinoma, NOS, of uterine adnexa	36518382	ICDO3
	Transitional cell carcinoma, NOS, of uterus, NOS	36540721	ICDO3
	Transitional cell carcinoma, NOS, of vagina, NOS	36551899	ICDO3
	Transitional cell carcinoma, NOS, of vallecula	36547955	ICDO3
	Transitional cell carcinoma, NOS, of vulva, NOS	36566466	ICDO3
Is a	Transitional cell papillomas and carcinomas	1553000	ICDO3
Non-standard to Standard map (OMOP)	Transitional cell carcinoma	4097829	SNOMED

License Agreement

In order to use the SNOMED International SNOMED CT Browser and HemOnc, please accept the following license agreement:

SNOMED INTERNATIONAL SNOMED CT LICENSE AGREEMENT

SNOMED International SNOMED CT Browser includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the SNOMED International. All rights reserved. SNOMED CT® was originally created by the College of American Pathologists.
“SNOMED”, “SNOMED CT” and “SNOMED Clinical Terms” are registered trademarks of the SNOMED International (www.snomed.org)

Use of SNOMED CT in SNOMED International SNOMED CT Browser is governed by the conditions of the following SNOMED CT license issued by SNOMED International:

The meaning of the terms “Affiliate”, or “Data Analysis System”, “Data Creation System”, “Derivative”, “End User”, “Extension”, “Member”, “Non-Member Territory”, “SNOMED CT” and “SNOMED CT Content” are as defined in the SNOMED International Affiliate License Agreement (see on the SNOMED International web site).
Information about Affiliate Licensing is available athttp://www.snomed.org/snomed-ct/get-snomed-ct. Individuals or organizations wishing to register as SNOMED International Affiliates can register at mlds.ihtsdotools.org, subject to acceptance of the Affiliate License Agreement (see on the SNOMED International web site).
The current list of SNOMED International Member Territories can be viewed at www.snomed.org/members. Countries not included in that list are "Non-Member Territories".
End Users, that do not hold an SNOMED International Affiliate License, may access SNOMED CT® using SNOMED International SNOMED CT Browser subject to acceptance of and adherence to the following sub-license limitations:
1. The sub-licensee is only permitted to access SNOMED CT® using this software (or service) for the purpose of exploring and evaluating the terminology.
2. The sub-licensee is not permitted the use of this software as part of a system that constitutes a SNOMED CT "Data Creation System" or "Data Analysis System", as defined in the SNOMED International Affiliate License. This means that the sub-licensee must not use SNOMED International SNOMED CT Browser to add or copy SNOMED CT identifiers into any type of record system, database or document.
3. The sub-licensee is not permitted to translate or modify SNOMED CT Content or Derivatives.
4. The sub-licensee is not permitted to distribute or share SNOMED CT Content or Derivatives.
SNOMED International Affiliates may use SNOMED International SNOMED CT Browser as part of a "Data Creation System" or "Data Analysis System" subject to the following conditions:
1. The SNOMED International Affiliate, using SNOMED International SNOMED CT Browsermust accept full responsibility for any reporting and fees due for use or deployment of such a system in a Non-Member Territory.
2. The SNOMED International Affiliate must not useSNOMED International SNOMED CT Browser to access or interact with SNOMED CT in any way that is not permitted by the Affiliate License Agreement.
3. In the event of termination of the Affiliate License Agreement, the use ofSNOMED International SNOMED CT Browser will be subject to the End User limitations noted in 4.

HemOnc license agreement

The HemOnc Vocabulary is a derivative product of HemOnc.org, which is wholly owned and operated by HemOnc.org LLC. Use of the HemOnc Vocabulary is governed by the conditions of this License Agreement issued by HemOnc.org LLC:

The meaning of the terms “Data Analysis System”, “Data Creation System”, and “License” is defined below.
If you are already holding a HemOnc ontology License, you are subject to the terms and conditions of the License for the version of the HemOnc Vocabulary which was provided to you. If you wish to obtain this version of the HemOnc Vocabulary, you are subject to the following limitations.
If you currently do not hold a HemOnc ontology License, you may access the HemOnc Vocabulary subject to acceptance of and adherence to the following limitations:
1. You are permitted to access HemOnc using this software for the purpose of exploring and evaluating the terminology.
2. You are permitted to use HemOnc as part of a system that constitutes a Data Analysis System, as defined below.
3. You are not permitted the use of HemOnc as part of a system that constitutes a Data Creation System, as defined below. This means that you must not use HemOnc identifiers in any type of system intended for direct or indirect patient care.
4. If you share the Licensed Material with a third party, attribution of the HemOnc vocabulary must be given to HemOnc.org LLC, with a URI or hyperlink to HemOnc.org provided if reasonably possible. Use of HemOnc by a third party would be limited to a Data Analysis System and a copy of this License Agreement must be supplied to the third party.
5. You may not use HemOnc as a substitute for formal medical training, substitute it for independent clinical judgment, and construe it as offering medical advice.

If you wish to utilize the vocabulary for purposes other than specified here, contact us by emailing licensing@hemonc.org.

You agree to indemnify and hold HemOnc.org LLC and all parties who have contributed to HemOnc.org and this derivative product harmless from and against all claims, liability, losses, damages, costs, and expenses, including--but not limited to--legal fees

Definitions

Data Analysis System: a computer system that is used to analyze records or other data, but not if that system is also a Data Creation System

Data Creation System: a computer system that is used to create records or other data that is encoded using HemOnc, for the purposes of facilitating patient care

License: the separate CC BY-NC-SA 4.0 license to the full HemOnc ontology

Details

Term connections (123)

Athena – OHDSI Vocabularies Repository

License Agreement

SNOMED INTERNATIONAL SNOMED CT LICENSE AGREEMENT

HemOnc license agreement